Forbes August 20, 2018
Dante Disparte

For a sector where the outcomes matter so much more than the inputs, the diagnosis on the U.S. healthcare industry is not great. The prognosis is not much better, especially as tectonic shifts are afoot in the U.S., which ranks last in The Commonwealth Fund’s benchmarking of advanced economy health systems. By this measure, the market making moves by Amazon’s triumvirate with JPMorgan Chase and Berkshire Hathaway should be watched very carefully as a portent for how technology (courtesy of Amazon), scale (courtesy of their combined 1 million employees), and financial and actuarial acumen (courtesy of JPMorgan and Berkshire Hathaway’s financial and insurance prowess), shape the industry. If the Amazon triumvirate is a very large beta test for how corporations...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Blockchain, Employer, Healthcare System, Insurance, Patient / Consumer, Provider, Technology, Trends
ONC @ 20: A Tale of Optimism and Humility
Race, Neighborhood Influence Lapses in Diabetic Retinopathy Care
Europe Strengthens Future Disease Defense
HIV Transmission Linked To Vampire Facials, Says CDC
Identifying Vulnerable Populations to Substandard or Falsified Drugs: A Global Health Challenge

Share This Article